Literature DB >> 12437529

Utilization of PD modalities: evolution.

Vijaya Venkataraman1, Karl D Nolph.   

Abstract

In the early 1960s, peritoneal dialysis (PD) was introduced as a form of long-term maintenance therapy in patients with end-stage renal disease (ESRD). We have come a long way since. Increasing understanding of peritoneal kinetic behavior, its innovative manipulation to meet patient needs, critical monitoring of clinical outcomes, and parallel development in technology have all contributed to the worldwide success of the therapy over the past four decades. In this article we review the evolution of the various PD modalities in the context of these factors.

Entities:  

Mesh:

Year:  2002        PMID: 12437529     DOI: 10.1046/j.1525-139x.2002.00095.x

Source DB:  PubMed          Journal:  Semin Dial        ISSN: 0894-0959            Impact factor:   3.455


  4 in total

1.  Clinical Factors Associated with Serum Magnesium Concentration in Patients Undergoing Peritoneal Dialysis: A Single-Center Observational Study.

Authors:  Shohei Kaneko; Susumu Ookawara; Yoshiyuki Morishita
Journal:  Int J Nephrol Renovasc Dis       Date:  2022-05-24

2.  Peritoneal phosphate clearance is influenced by peritoneal dialysis modality, independent of peritoneal transport characteristics.

Authors:  Sunil V Badve; Deborah L Zimmerman; Greg A Knoll; Kevin D Burns; Brendan B McCormick
Journal:  Clin J Am Soc Nephrol       Date:  2008-09-24       Impact factor: 8.237

Review 3.  Continuous ambulatory peritoneal dialysis versus automated peritoneal dialysis for end-stage renal disease.

Authors:  K S Rabindranath; J Adams; T Z Ali; A M MacLeod; L Vale; J Cody; S A Wallace; C Daly
Journal:  Cochrane Database Syst Rev       Date:  2007-04-18

4.  Association between carnitine deficiency and the erythropoietin resistance index in patients undergoing peritoneal dialysis: a cross-sectional observational study.

Authors:  Shohei Kaneko; Keiji Hirai; Junki Morino; Saori Minato; Katsunori Yanai; Yuko Mutsuyoshi; Hiroki Ishii; Momoko Matsuyama; Taisuke Kitano; Mitsutoshi Shindo; Akinori Aomatsu; Haruhisa Miyazawa; Yuichiro Ueda; Kiyonori Ito; Susumu Ookawara; Yoshiyuki Morishita
Journal:  Ren Fail       Date:  2020-11       Impact factor: 2.606

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.